866929-82-0

Basic information

• Product Name: 5-bromo-2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridine
• Synonyms: 5-bromo-2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridine
• CAS NO: 866929-82-0
• Molecular Formula: C₁₃H₁₈BrNSi
• Molecular Weight: 296
• Mol File: 866929-82-0.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-bromo-2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridine(866929-82-0)
• EPA Substance Registry System: 5-bromo-2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridine(866929-82-0)

Safety Data

• Hazardous Substances Data: 866929-82-0(Hazardous Substances Data)

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 86318-61-8 (tert-butyldimethylsilyl)acetylene 
• 87290-98-0 (3,3-dimethylbut-1-yn-1-yl)dimethylsilane 
• 223463-13-6 2-iodo-5-bromopyridine 

Downstream Products

• 866929-83-1 2-[(tert-butyl-dimethyl-silanyl)-ethynyl]-5-(4-chloro-phenyl)-pyridine 
• 866931-05-7 cis-1-{6-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridin-3-yl}-4-methyl-cyclohexanol 
• 866930-62-3 trans-1-{6-[(tert-butyl-dimethyl-silanyl)-ethynyl]-pyridin-3-yl}-4-methyl-cyclohexanol 
• 1363438-79-2 2-((tert-Butyldimethylsilyl)ethynyl)-5-p-tolylpyridine 
• 1488359-60-9 C₅₅H₅₃BrN₅O₄Pt⁽¹⁺⁾*C₇H₇O₃S^(1-) 
• 111770-86-6 2-ethynyl-5-bromo-pyridine 
• 1488359-58-5 2-(1-(2-phenylethyl)-1H-1,2,3-triazol-4-yl)-5-bromopyridine 

Relevant articles and documents

Acid-base responsive switching between 3+1 and 2+2 platinum complexes

We report that the acid-base induced changes to a cyclometallated platinum complex can be used to drive the exchange of accompanying ligands with different denticities.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds of formula I wherein A, B, W, X, Y, Z, R1, and R2 have the meanings given herein, which have MCH-receptor antagonistic activity and are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.